A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation
Sophia Koo(Dana-Farber Brigham Cancer Center), Francisco M. Marty(Brigham and Women's Hospital), David W. Kubiak(Harvard University), Phillip C. Camp(Brigham and Women's Hospital), Amanda Dietzek(Brigham and Women's Hospital), Hilary J. Goldberg(Harvard University), Steve Boukedes(Brigham and Women's Hospital), Nicolas C. Issa(Dana-Farber Cancer Institute), Lindsey R. Baden(Brigham and Women's Hospital), Anne L. Fuhlbrigge(Brigham and Women's Hospital)
Cited by 40
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k